Bullous Pemphigoid Developed after the COVID-19 Vaccine.

Linares-Navarro, Rubén; Ramírez, Gorka Ruiz-Carrillo; Perandones-González, Héctor; Rodríguez-Prieto, Manuel Ángel

Linares-Navarro, Rubén; Ramírez, Gorka Ruiz-Carrillo; Perandones-González, Héctor; Rodríguez-Prieto, Manuel Ángel.

Afiliação

Linares-Navarro R; Department of Dermatology, University Hospital of Leon, León, Spain; rlinares@saludcastillayleon.es.
Ramírez GR; Department of Dermatology, University Hospital of Leon, León, Spain.
Perandones-González H; Department of Dermatology, University Hospital of Leon, León, Spain.
Rodríguez-Prieto MÁ; Department of Dermatology, University Hospital of Leon, León, Spain.

Skinmed ; 21(3): 200-202, 2023.

Article em En | MEDLINE | ID: mdl-37634107

Assuntos

COVID-19; Penfigoide Bolhoso; Masculino; Humanos; Idoso de 80 Anos ou mais; Vacinas contra COVID-19/efeitos adversos; Vacina BNT162; Penfigoide Bolhoso/etiologia; COVID-19/prevenção & controle; Vesícula

Buscar no Google

Imprimir

XML

PubMed Links

Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / COVID-19 Tipo de estudo: Etiology_studies Limite: Aged80 / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Buscar no Google

Imprimir

XML

PubMed Links